Latest stories on PGEN
Precigen call volume above normal and directionally bullish
The Fly63 · neutralgeneral
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Yahoo Finance63 · neutralgeneral
Precigen: The FDA's Platform Technology Designation And The Institutional Crossover Effect
Seeking Alpha73 · bullishproduct/pr
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today?
Stocktwits News67 · bullishgeneral
B.Riley initiates Precigen stock coverage with buy on drug launch
Investing.com Analyst Ratings61 · neutralanalyst
Precigen initiated with a Buy at B. Riley
The Fly61 · neutralanalyst
Precigen Wins FDA Platform Technology Designation for AdenoVerse, Opening a Faster Path for Future Programs
September 21, 2026
MarketChameleon73 · bullishproduct/pr
Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform
PR Newswire67 · bullishproduct/pr
Precigen Q2 marked commercial inflection
The Fly63 · neutralearnings
Precigen (PGEN) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Precigen: Has To Grow Into Its Valuation
Seeking Alpha48 · neutralgeneral
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement
Seeking Alpha67 · bullishanalyst
PAPZIMEOS Drives Precigen to Profitability as Revenue More Than Doubles: What the Numbers Reveal
August 5, 2026
MarketChameleon73 · bullishearnings
PGEN Achieves Profitability on Accelerating PAPZIMEOS Revenue and Expands US Market Reach
August 5, 2026
MarketChameleon73 · bullishproduct/pr
Precigen, Inc. (PGEN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Precigen GAAP EPS of $0.05 beats by $0.06, revenue of $54.98M beats by $27.15M
Seeking Alpha68 · bullishearnings
PRECIGEN, INC. (PGEN) files 8-K
SEC 8-K50 · neutralgeneral
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
PR Newswire67 · bullishearnings
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4
PR Newswire50 · neutralgeneral
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
Yahoo Finance42 · neutralgeneral
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
The Motley Fool42 · neutralgeneral
Precigen: Entering The Oncology 'Sweet Spot'
Seeking Alpha73 · bullishanalyst
PRECIGEN, INC. (PGEN) files 8-K
SEC 8-K50 · neutralgeneral
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
Yahoo Top73 · bullishearnings